A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue
Conditions
- Pediatric Sarcoma, Refractory
- Pediatric Sarcoma, Relapsed
Interventions
- BIOLOGICAL: GEM/DOX + TGFBi expanded NK cells
Sponsor
Nationwide Children's Hospital
Collaborators